Prognostic implications of procedural vs spontaneous myocardial infarction: Results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry
Tóm tắt
Từ khóa
Tài liệu tham khảo
Novack, 2012, Troponin criteria for myocardial infarction after percutaneous coronary intervention, Archives of internal medicine, 172, 502, 10.1001/archinternmed.2011.2275
Vranckx, 2012, Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting, Heart, 98, 1424, 10.1136/heartjnl-2012-302267
Pervaiz, 2012, Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions, Circ Cardiovasc Interv, 5, 150, 10.1161/CIRCINTERVENTIONS.111.965566
Nienhuis, 2008, Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis, Catheter Cardiovasc Interv, 71, 318, 10.1002/ccd.21345
Cockburn, 2012, Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE), Heart, 98, 1431, 10.1136/heartjnl-2012-302211
Lindsey, 2011, Prognostic implications of creatine kinase–MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry, Circ Cardiovasc Interv, 4, 474, 10.1161/CIRCINTERVENTIONS.111.962233
Ioannidis, 2003, Mortality risk conferred by small elevations of creatine kinase–MB isoenzyme after percutaneous coronary intervention, J Am Coll Cardiol, 42, 1406, 10.1016/S0735-1097(03)01044-1
Stone, 2001, Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients, Circulation, 104, 642, 10.1161/hc3101.093902
Brener, 2002, Frequency and long-term impact of myonecrosis after coronary stenting, Eur Heart J, 23, 869, 10.1053/euhj.2001.2976
Akkerhuis, 2002, Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?, Circulation, 105, 554, 10.1161/hc0502.104278
Jacob, 2005, Design of a registry to characterize “real-world” outcomes of percutaneous coronary revascularization in the drug-eluting stent era, Am Heart J, 150, 887, 10.1016/j.ahj.2005.03.030
Spreeuwenberg, 2010, The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health, Med Care, 48, 166, 10.1097/MLR.0b013e3181c1328f
Rosenbaum, 1983, The central role of propensity score in observational studies for causal effects, Biometrika, 70, 41, 10.1093/biomet/70.1.41
Rubin, 2001, Using propensity score to help design observational studies: application to the tobacco litigation, Health Serv Outcomes Res Methodol, 2, 169, 10.1023/A:1020363010465
D'Agostino, 1998, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, Statistics in medicine, 17, 2265, 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
Imbens, 2000, The role of the propensity score in estimating dose-response functions, Biometrika, 87, 706, 10.1093/biomet/87.3.706
Califf, 1998, Myonecrosis after revascularization procedures, J Am Coll Cardiol, 31, 241, 10.1016/S0735-1097(97)00506-8
French, 2004, Clinical implications of the new definition of myocardial infarction, Heart, 90, 99, 10.1136/heart.90.1.99
Davis, 2013, Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79, Circulation, 127, 980, 10.1161/CIRCULATIONAHA.112.000908
Pervaiz, 2012, Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions, Circ Cardiovasc Interv, 5, 150, 10.1161/CIRCINTERVENTIONS.111.965566
Fox, 2006, Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE), BMJ, 333, 1091, 10.1136/bmj.38985.646481.55
Thygesen, 2012, Third universal definition of myocardial infarction, Circulation, 126, 2020, 10.1161/CIR.0b013e31826e1058
Apple, 2007, National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes, Circulation, 115, e352